Financials
- Market Capitalization 870.94 M
- Employee 371
- Founded 2018
- CEO N/A
- Website www.phathompharma.com
- Headquarter Delaware, United States
- FIGI BBG00P5B2S19
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-5.48
売上高対価格比率
6.91
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2535 | GERN Geron Corporation - Common Stock | 1.42 USD | -5.33% | -1.39% | +22.41% | +6.77% | 910.96 M USD | ||
| 2558 | TBPH Theravance Biopharma, Inc. - Ordinary Shares | 16.90 USD | -0.18% | -0.59% | +1.75% | +17.77% | 871.25 M USD | ||
| 2561 | DSGN Design Therapeutics, Inc. - Common Stock | 13.86 USD | -8.76% | -7.41% | +24.98% | +248.24% | 865.65 M USD | ||
| 2588 | REPL Replimune Group, Inc. - Common Stock | 9.94 USD | -9.55% | -14.38% | +12.83% | -13.34% | 834.41 M USD |